IRIN examines WHO's efforts to communicate HIV risk among injectable hormonal contraceptive users

Published on December 7, 2012 at 4:51 AM · No Comments

IRIN examines the WHO's ongoing efforts to synthesize and communicate guidance about the risk of HIV infection and transmission for women taking injectable hormonal contraception, including a meeting scheduled for this week in Geneva. The news service looks at the history of the issue, including "a February 2012 [WHO] statement standing by current guidelines allowing women living with or at high risk of HIV to use hormonal contraception" and advising women on injectable contraception to use condoms concurrently; reaction from representatives of non-governmental organizations and WHO officials; and efforts by researchers to "formulat[e] a concept note on a clinical trial that could be the world's first to examine whether hormonal contraception does indeed increase HIV risk" (12/5).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Immunologic mechanism makes broadly neutralizing antibodies in people infected with HIV